Clinical Trials Directory

Trials / Completed

CompletedNCT04507776

Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel

Long Term Adherence and Efficacy of Etanercept in SpA Iraqi Patients: 7 Year Data From Local Registry

Status
Completed
Phase
Study type
Observational
Enrollment
763 (actual)
Sponsor
Pfizer · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is to evaluate local data in Iraqi patients with Spondyloarthropathies on Enbrel treatment with regards to efficacy and adherence using data from the Baghdad Teaching Hospital (Rheumatology Center)

Conditions

Interventions

TypeNameDescription
DRUGEtanerceptPatients with spondyloarthrosis as provided in real world practice

Timeline

Start date
2020-09-01
Primary completion
2020-10-01
Completion
2020-10-01
First posted
2020-08-11
Last updated
2021-10-04
Results posted
2021-10-04

Locations

1 site across 1 country: Iraq

Source: ClinicalTrials.gov record NCT04507776. Inclusion in this directory is not an endorsement.

Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel (NCT04507776) · Clinical Trials Directory